Nathan Bryan, PhD

Nathan Bryan, PhD


Dr. Bryan has been involved in nitric oxide research for the past 20 years and has made many seminal discoveries in the field. His many discoveries have resulted in dozens of issued US and International patents and the product technology resulting from his discoveries and inventions has improved patient care worldwide.

Dr. Bryan is an international leader in molecular medicine and nitric oxide biochemistry. He is a successful entrepreneur and has founded multiple companies. His technology is responsible for hundreds of millions of product sales worldwide. Most recently, Dr. Bryan serves as Founder and CEO of Nitric Oxide Innovations, LLC, a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of nitric oxide-based therapies. Their lead drug candidate NOviricid is currently in phase 3 clinical trials for the treatment of COVID19 in African Americans and Hispanics.

Education and Training

  • Faculty, University of Texas Health Science Center at Houston
  • Kirschstein Fellow, Boston University School of Medicine, Whitaker Cardiovascular Institute
  • Doctoral degree, Louisiana State University School of Medicine
  • Dean's Award, Excellence in Research
  • Bachelor of Science, University of Texas at Austin

Professional Highlights

  • Founder, HumanN, Inc.
  • Founder, Pneuma Nitric Oxide, LLC
  • Founder, Nitric Oxide Innovations, LLC
  • Founder, Bryan Nitriceuticals, LLC